drug
EXDENSUR
updated 6mo agoby GlaxoSmithKline LLC
community read0 votes
🐶 often sniffed alongside
top 3all catalysts(0)
nothing on the calendar yet
News(2)
- Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting gameLilly’s better-than-expected results allayed concerns — for now — over GLP-1 pricing pressure. Elsewhere, Novartis withstood a tumultuous quarter and GSK battled investor angst.biopharma_dive · 20d ago
- GSK vaccine sales miss expectations amid falling demand from adultsWith pressure on GSK’s vaccine business, analysts predict the U.K. pharma will face challenges as it prepares for the loss of exclusivity on a key product.biospace · 22d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that